SHERRY MILLER: Open Payments
NPI 1184604878 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 73 payments from 18 companies in 2025. Trend: 2023 $628 · 2024 $2,786 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $192 |
| PFIZER INC. | 12 | $184 |
| Novo Nordisk Inc | 14 | $169 |
| ABBVIE INC. | 7 | $135 |
| Dexcom, Inc. | 5 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Abbott Laboratories | 3 | $52 |
| Medtronic, Inc. | 3 | $43 |
Products named: FARXIGA, Dexcom G6 Transmitter, Kerendia, QULIPTA, Ozempic, ELIQUIS, NURTEC ODT, Rybelsus.
Industry payments across KY — which companies pay providers there.
